1672 fundamentals
An in-depth look to ASCLETIS PHARMA INC operating, investing, and financing activities
1672 free cash flow for H2 23 is -87.88 M HKD. For 2023, 1672 free cash flow was -166.16 M HKD and operating cash flow was -159.3 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM